Merck Investor Relations Material
Latest events
Q1 2025
Merck
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Merck KGaA
Access all reports
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. The company's Life Science business segment focuses on the development, manufacture, marketing and distribution of pharmaceutical products. It offers drugs for a range of therapeutic indications from central nervous system diseases to cardiovascular and metabolic disorders. In addition to its own pharmaceutical activities, MERCK helps develop medicines for customers. The company also participates in the development of active substances with partners.
Key slides for Merck KGaA
CMD 2024
Merck KGaA
CMD 2024
Merck KGaA
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MRK
Country
🇩🇪 Germany